Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1901-1910 of 2244 for

Edit search filters
  1. A Study of Photon and Proton Chemoradiotherapy as Definitive or Neoadjuvant Therapy in Non-Metastatic Pancreatic Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. A Study to Evaluate the Use of Organoids to Advance Precision Medicine in Bladder Cancer

    Rochester, MN

  3. Use of Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy and Risk of Malignancy in Genetic Mutation Carriers

    Rochester, MN

  4. Multiple Myeloma Patient Registry

    Jacksonville, FL

  5. informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia

    Jacksonville, FL

  6. Open Nipple Sparing Mastectomy (NSM)

    Rochester, MN

  7. Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index

    Rochester, MN

  8. Semen Analysis in Chemotherapy

    Rochester, MN

  9. Preclinical drug testing and assay development for lung adenocarcinoma characterized by the expression of ASCL1

    Rochester, MN

  10. A Study to Evaluate Immune Response Changes to Ovarian Cancer During Chemotherapy

    Rochester, MN

.

Mayo Clinic Footer